Undark
From this contributor
Evidence linking acetaminophen to autism, ADHD under debate again
As acetaminophen lawsuits make their way through the U.S. court system, researchers reevaluate the quality of the evidence linking in-utero exposure to the painkiller to neurodevelopmental issues in children.
Evidence linking acetaminophen to autism, ADHD under debate again
Psychology research skews mostly white and wealthy
For decades, the overwhelming majority of psychology research has examined people who live in the United States and other affluent Western countries — presenting a skewed view of the human mind.
Psychology research skews mostly white and wealthy
The cost of a delayed autism diagnosis
Many people go more than half of their lives before learning that they are autistic; one writer on the spectrum believes we can do better.
The cost of a delayed autism diagnosis
Canada makes clinical trial data available to public
Canada's health department is now sharing study results on new drugs and treatments online. Transparency advocates want the United States to do the same.
Canada makes clinical trial data available to public
What it’s like to be autistic at an autism research conference
An autistic journalist is cautiously optimistic that the annual INSAR conference is becoming more inclusive of the autism community.
What it’s like to be autistic at an autism research conference
Explore more from The Transmitter
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.